2007/03/20 by Heather Piwowar, Roger Day, Douglas B. Fridsma · 3 citations
Computer Science · Biochemistry, Genetics and Molecular Biology · Decision Sciences · Medicine · #Research Data Management Practices #Biomedical Text Mining and Ontologies #Meta-analysis and systematic reviews #Citation #Data sharing #Clinical trial #Data science #Impact factor #Aggregate data #Computer science #MEDLINE #Medicine #Bioinformatics #Alternative medicine #Internal medicine #Library science #Biology #Pathology
paper · doi:10.1371/journal.pone.0000308
openalex publication_date 2007/03/20 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/06
BACKGROUND: Sharing research data provides benefit to the general scientific community, but the benefit is less obvious for the investigator who makes his or her data available. PRINCIPAL FINDINGS: We examined the citation history of 85 cancer microarray clinical trial publications with respect to the availability of their data. The 48% of trials with publicly available microarray data received 85% of the aggregate citations. Publicly available data was significantly (p = 0.006) associated with a 69% increase in citations, independently of journal impact factor, date of publication, and author country of origin using linear regression. SIGNIFICANCE: This correlation between publicly available data and increased literature impact may further motivate investigators to share their detailed research data.